Physicochemical Properties
| Molecular Formula | C18H23CLN4OS |
| Molecular Weight | 378.92 |
| Exact Mass | 378.128 |
| CAS # | 1216398-09-2 |
| PubChem CID | 45073464 |
| Appearance | White to light yellow solid powder |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 25 |
| Complexity | 484 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WYTJVUVCSUWZTH-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C18H22N4OS.ClH/c1-11-16(17(23)21(2)13-6-4-3-5-7-13)24-18-20-14-9-8-12(19)10-15(14)22(11)18;/h8-10,13H,3-7,19H2,1-2H3;1H |
| Chemical Name | 7-amino-N-cyclohexyl-N,1-dimethyl-[1,3]thiazolo[3,2-a]benzimidazole-2-carboxamide;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | mGluR 1 |
| ln Vitro | For rat mGluR1-NIH membranes, YM-298198 hydrochloride exhibits a strong affinity for mGluR1 with a Ki of 19 nM[1]. With an IC50 of 16 nM, YM-298198 hydrochloride suppresses glutamate-induced inositol phosphate synthesis in mGluR1-NIH3T3 cells[1]. When applied to mGluR2, 3, 4a, 6, or 7b, YM-298198 hydrochloride exhibits neither agonistic nor antagonistic activity up to 10 μM[1]. |
| ln Vivo | Mice with streptozotocin-induced hyperalgesia exhibit a notable analgesic response when given YM-298198 hydrochloride (30 mg/kg; po)[1]. |
| Animal Protocol |
Animal/Disease Models: Male ICR mice[1] Doses: 30 mg/kg Route of Administration: Oral administration Experimental Results: Prolonged nociceptive response latency in streptozotocin (200 mg/kg)-induced hyperalgesic mice. |
| References |
[1]. Radioligand Binding Properties and Pharmacological Characterization of 6-Amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a High-Affinity, Selective, and Noncompetitive Antagonist of Metabotropic Glu. |
Solubility Data
| Solubility (In Vitro) | DMSO: 125 mg/mL (329.88 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6391 mL | 13.1954 mL | 26.3908 mL | |
| 5 mM | 0.5278 mL | 2.6391 mL | 5.2782 mL | |
| 10 mM | 0.2639 mL | 1.3195 mL | 2.6391 mL |